Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs The Coca-Cola Co K — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while The Coca-Cola Co K trades at $92.69 (market cap $387.70B). The key difference: The Coca-Cola Co K is far larger — about 12.5× GE HealthCare Technologies Inc. Common Stock's market cap, and The Coca-Cola Co K pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| GEHC | KO | |
|---|---|---|
Market Cap | $31.07B | $387.70B |
Volume | 3,443,020 | 15,313,783 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $91.99 |
52-Week Low | $59.48 | $67.08 |
Enterprise Value | $39.53B | $414.87B |
Dividend Yield | 0.23% | 2.35% |
Typical Hold Time | — | 154 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Coca-Cola (KO) trades at $90.11, up 0.36% with strong technical momentum as it approaches resistance near $91. The company demonstrates robust fundamentals with Q2 2026 EPS of $0.97 beating expectations, maintaining a 61.89% gross margin and 28.56% net margin. Recent institutional buying activity and the upcoming $0.53 dividend payment reflect positive sentiment. The stock trades at a P/E of 27.06, above sector averages, while analyst consensus targets $95.75 with 60% buy ratings.
Outlook remains favorable with projected 2026 revenue growth to $50.1B and net income of $14.3B. Key risks include high valuation multiples and regional demand divergence. The technical setup suggests near-term consolidation with support at $88, while fundamental strength supports long-term dividend growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
